News
PRPH
--
0.00%
--
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.
Benzinga · 54m ago
Insider Trends: Insider Purchase of ProPhase Labs Stock Extends 90-Day Positive Trend
MT Newswires · 3d ago
Trxade, ProPhase Labs leads healthcare gainers; Aethlon Medical, Ocugen among major losers
Gainers: Trxade (MEDS) +100%, Reneo Pharmaceuticals (RPHM) +13%, ProPhase Labs (PRPH) +18%, Verona Pharma (VRNA) +13%, Myomo (MYO) +8%.Losers: Aethlon Medical (AEMD) -28%, Ocugen (OCGN) -23%, Ra Medical Systems (RMED) -16%, SCWorx (WORX) -12%, Genetic Tech...
Seekingalpha · 3d ago
ProPhase Labs Forms Two New Subsidiaries
marketwatch.com · 3d ago
ProPhase Labs Announces Formation Of ProPhase Precision Medicine And ProPhase Global Healthcare Subsidiaries
ProPhase Labs, Inc. (NASDAQ:PRPH), a diversified medical science and technology company, today announced the formation of two wholly-owned subsidiaries, ProPhase Precision Medicine, Inc., which will focus on genomics
Benzinga · 3d ago
BRIEF-Prophase Labs Diversifies With Formation Of Genomics And Global Healthcare Subsidiaries
reuters.com · 3d ago
ProPhase Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries
ProPhase Precision Medicine, Inc. and ProPhase Global Healthcare, Inc. to Expand Opportunities in Genomics and International Testing Services ProPhase Diagnostics, Inc. Developing New Testing Capabilities through Research and Acquisition CEO Ted Karkus to ...
GlobeNewswire · 3d ago
44 Biggest Movers From Friday
Gainers
Benzinga · 06/01 09:21
ONVO, YEXT, CTRM and SLCA among midday movers
Gainers: SemiLEDs (LEDS) +49%.Vertex Energy (VTNR) +45%.Organovo (ONVO) +28%.eMagin (EMAN) +24%.Mannatech (MTEX) +21%.Welbilt (WBT) +21%.Yext (YEXT) +19%.MoSys (MOSY) +16%.Embotelladora Andina (AKO-B) +13%.Iterum Therapeutics (ITRM) +17%.Losers: 1847 Goede...
Seekingalpha · 05/28 16:39
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 05/28 16:32
ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference
CEO Ted Karkus to Present at Conference on Thursday, June 10th, 2021
GlobeNewswire · 05/28 12:30
It May Be Possible That ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO Compensation Could Get Bumped Up
The decent performance at ProPhase Labs, Inc. ( NASDAQ:PRPH ) recently will please most shareholders as they go into...
Simply Wall St. · 05/14 06:36
ProPhase Labs EPS in-line, beats on revenue
ProPhase Labs (PRPH): Q1 GAAP EPS of $0.06 in-line.Revenue of $15.3M (+709.5% Y/Y) beats by $2.58M.Press Release
Seekingalpha · 05/13 20:55
ProPhase Labs declares $0.30 special dividend
ProPhase Labs (PRPH) declares $0.30/share special dividend.Payable June 3; for shareholders of record May 25; ex-div May 24.See PRPH Dividend Scorecard, Yield Chart, & Dividend Growth.
Seekingalpha · 05/13 20:49
ProPhase Labs Announces Special Cash Dividend of 30c/Shr
By Stephen Nakrosis Medical science and technology company ProPhase Labs Inc. on Thursday said its board declared a special cash dividend of 30 cents a...
marketwatch.com · 05/13 20:43
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers
Benzinga · 05/13 20:39
ProPhase Labs: Q1 Earnings Insights
Shares of ProPhase Labs (NASDAQ:PRPH) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 185.71% year over year to $0.06, which missed the estimate of $0.20.
Benzinga · 05/13 20:36
ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend
First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business
GlobeNewswire · 05/13 20:24
Webull provides a variety of real-time PRPH stock news. You can receive the latest news about Prophase Lab through multiple platforms. This information may help you make smarter investment decisions.
About PRPH
ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.